Tag: personalized treatment strategies for MSI-H tumors

Combination immunotherapy and chemotherapy improves progression-free survival for patients with metastatic dMMR colorectal cancer

by SCIENMAG

July 30, 2026

PITTSBURGH, PA – Patients with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer experienced a 58% ...

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

Tag: personalized treatment strategies for MSI-H tumors

Combination immunotherapy and chemotherapy improves progression-free survival for patients with metastatic dMMR colorectal cancer

Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

Bee body mass, pathogens and local climate influence heat tolerance

Researchers record first-ever images and data of a shark experiencing a boat strike

Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

RECENT NEWS

Categories

Subscribe to Blog via Email

Welcome Back!

Retrieve your password